HIGHLIGHTS
- What: This case report illustrates the role of andexanet alfa as an effective reversal agent for managing ICH in anticoagulated patients on FXa inhibitors, such as apixaban.
- Who: Corina Roman et al. from the Neurology, County Clinical Emergency Hospital of Sibiu, Sibiu, ROU Hematology, Lucian Blaga University of Sibiu have published the research: Review began 11/25/2024 Review ended 11/28/2024 Published 11/29/2024 © Copyright, in the Journal: (JOURNAL) of November/29,/2024
SUMMARY
Intracerebral hemorrhage (ICH) accounts for about 15% of strokes, with a high mortality rate . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.